Elisha Fielding is an accomplished professional with extensive experience in biomedicine and a strong background in program management, process development, and analytical science. Currently serving as Director at Sail Biomedicines since July 2023, Elisha previously held various key roles at GreenLight Biosciences, Inc., where responsibilities included leading cross-functional teams and managing projects aimed at streamlining processes for mRNA production and biopesticide development. Elisha's academic credentials include a PhD in Chemistry/Chemical Biology from Boston College and a BS in Chemistry from The University of Tennessee at Chattanooga. With a solid foundation in both research and leadership, Elisha has made significant contributions across reputable institutions, including Boston Children's Hospital and Shire HGT.